Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) — Cash Flow Quality Index
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Cash Flow Quality Index of 2.32x as of June 2023. Operating cash flow of €2.10 Billion exceeds net income of €902.65 Million, indicating high earnings quality where cash backs reported profits. Explore Guangzhou Baiyunshan Pharmaceutical Hold (GU5) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Guangzhou Baiyunshan Pharmaceutical Hold generate cash.
Annual Cash Flow Quality Index for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2025)
Year-by-year earnings quality comparison for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.08x | €-232.46 Million | €2.98 Billion | ▼ -106.4% |
| 2024 | 1.21x | €3.44 Billion | €2.84 Billion | ▲ +20.0% |
| 2023 | 1.01x | €4.10 Billion | €4.06 Billion | ▼ -42.7% |
| 2022 | 1.76x | €7.00 Billion | €3.97 Billion | ▲ +15.7% |
| 2021 | 1.53x | €5.67 Billion | €3.72 Billion | ▲ +659.8% |
| 2020 | 0.20x | €585.19 Million | €2.92 Billion | ▼ -87.3% |
| 2019 | 1.57x | €5.02 Billion | €3.19 Billion | ▲ +3.9% |
| 2018 | 1.52x | €5.22 Billion | €3.44 Billion | ▲ +70.5% |
| 2017 | 0.89x | €1.83 Billion | €2.06 Billion | ▼ -47.3% |
| 2016 | 1.69x | €2.54 Billion | €1.51 Billion | ▲ +13.0% |
| 2015 | 1.49x | €1.94 Billion | €1.30 Billion | ▲ +2.0% |
| 2014 | 1.46x | €1.75 Billion | €1.19 Billion | ▲ +7.4% |
| 2013 | 1.36x | €1.34 Billion | €980.05 Million | — |